A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00091663 · COMPLETED

Trial details

NCT number: NCT00091663
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Non-small-cell Lung Carcinoma

Start date: 2004-08-01
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.